Latest Biotechnology, Pharmaceutical and Healthcare News from in-PharmaTechnologis

21:39 EDT 24th March 2018 | BioPortfolio

Here are the most relevant search results for "in-PharmaTechnologis" found in our extensive news archives from over 250 global news sources.

More Information about in-PharmaTechnologis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about in-PharmaTechnologis for you to read. Along with our medical data and news we also list in-PharmaTechnologis Clinical Trials, which are updated daily. BioPortfolio also has a large database of in-PharmaTechnologis Companies for you to search.

Showing News Articles 1–25 of 427 from in-PharmaTechnologis

Thursday 22nd March 2018

Blockchain for pharma: DHL, Imperial and Authentag embrace ledger tech

Three contract services firms have launched separate Blockchain-based initiatives, in a bid to increase pharmaceutical supply chain security.

Alembic receives FDA 483, but no repeat observations nor data issues

Alembic Pharmaceuticals has received a US FDA Form 483 with three observations at a finished formulation plant in Gujarat, India.

IPEC and PDA team on excipient risk assessment guidance

IPEC Federation and PDA will publish a technical report in 2019 to provide drugmakers guidelines on how to implement risk assessment challenges of excipient supply.

Wednesday 21st March 2018

Contamination risk from vermin lands Indian API firm with US warning

Inspectors observed birds and insects inside an API facility run by Malladi Drugs & Pharmaceuticals, according to a US FDA warning letter.

Noramco signs AMPAC to top up API and intermediates supply

AMPAC Fine Chemicals will boost Noramco Inc.âs supply of active pharmaceutical ingredients and intermediates to make abuse prevention and attention deficit disorder treatments, and cannabinoids.

Scientists develop ‘nanospear’ tech for cell and gene therapies

âSplinter-likeâ nanostructures have been developed by researchers in the US to deliver biomolecules straight into patient cells for immune-oncology and gene therapies.

Tuesday 20th March 2018

Synthetic peptide platform to make orally active, room-temperature vaccines

Researchers are developing a vaccine production platform designed to make ingestible, temperature-stable synthetic drugs.

Sterling taps Nanologica tech for peptide purification

Sterling Pharma Solutions says it will boost its chromatography services with Nanologicaâs silica particles production technology.

Thermo Fisher plans operations reshuffle and 170 job cuts in UK

Thermo Fisher Scientific says its proposal to move manufacturing and R&D operations from Ashford, Kent to existing sites in Mexico, China and Denmark was a âvery difficult decision.â

Monday 19th March 2018

Lundbeck to buy Prexton in potential $1bn+ deal

The Danish drugmaker says it will take responsibility for commercial manufacturing after acquiring Parkinsonâs disease candidate foliglurax in a deal worth up to â905m ($1.1bn).

Dr Reddy's receives FDA 483 at Indian API plant

The US FDA has issued a Form 483 with four observations to an API facility in Hyderabad, India run by Dr Reddyâs Laboratories.

Thursday 15th March 2018

Dutch API maker bought by CDMO to boost development offering

CDMO Ardena has purchased active pharmaceutical ingredient and nanomedicine maker ChemConnection, as part of an acquisition strategy focused on development services.

PCI to tackle ‘wait and see’ approach with serialization suite in Ireland

PCI Pharma Services has validated its former Millmount site to help Irelandâs âthriving pharma communityâ comply with Europeâs Falsified Medicines Directive.

Upperton upping spray-dry production in $2m relocation

Spray-drying service provider Upperton Pharma Solutions has expaned to offer GMP manufacturing for early-stage clinical trials.

US FDA slams French lab for compromising supply chain accountability

Contract analysis firm Quali-Controle & Quali-Controle has received a US FDA warning after violating GMP in the testing of finished pharmaceuticals.

Wednesday 14th March 2018

Capsule maker ups track and trace with molecular tagging

ACG says adding Applied DNA Sciencesâ molecular tagging and authentication technology to its capsule products will increase supply chain security.

Online ‘quality assured’ API trading platform to launch this year

Kemiex has established an online platform to facilitate the trade of active pharmaceutical ingredients between drugmakers and distributors.

Tuesday 13th March 2018

‘Limited competition’ for Pfizer generic drives launch rejig

A lack of generic competition for Pfizerâs contraceptive Depo-Provera has influenced Amphastarâs decision to prioritise its pre-filled syringe version, says executive.

New method to predict drug stability a boon for pharma

A new method to predict the physical stability of drug candidates is attracting interest from pharmaceutical companies who could use the technology to de-risk early development.

A new era of medicine? Industry poised for change, says PhRMA

The industry is set up to accelerate the availability of new patient options in a ânew era of medicineââ though robust intellectual property protection is critical to continued innovation.

The Good, The Bad and the Ugly of CMO partnerships: A biotech perspective

Partnering with CMOs makes sense for emerging biotechs, says Ardelyx exec James Kanter, who relies on networking and clear communication guidelines to manage third-party relationships.

Codexis hunts next Big Pharma license deal for biocatalyst engineering platform

With GSK and Merck & Co. no longer on the books, Codexis is looking to secure its next CodeEvolver license deal.

Codexis hunts next Big Pharma license deal for protein engineering platform

With GSK and Merck & Co. no longer on the books, Codexis is looking to secure its next CodeEvolver license deal.

Monday 12th March 2018

Anticancer delivery tech to reduce tissue damage an ‘unexpected surprise’

Researchers are developing light-sensitive nanocontainers they say can deliver anticancer drugs to precise locations, at exact times.

Renewed interest in ‘understudied’ co-crystals to drive better meds, says scientist

Pharmaceutical co-crystals can improve the properties of active substances and ultimately make better medicines, says researcher.

Quick Search


News Quicklinks